Technical Analysis for OSIR - Osiris Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
OSIR closed up 4.53 percent on Tuesday, December 11, 2018, on 7.21 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical OSIR trend table...|
|Date||Alert Name||Type||% Chg|
|Dec 11||New 52 Week Closing High||Bullish||0.00%|
|Dec 11||Pocket Pivot||Bullish Swing Setup||0.00%|
|Dec 11||Volume Surge||Other||0.00%|
|Dec 11||New 52 Week High||Strength||0.00%|
|Dec 11||Upper Bollinger Band Walk||Strength||0.00%|
|Dec 11||Wide Bands||Range Expansion||0.00%|
|Dec 11||Above Upper BB||Strength||0.00%|
|Dec 11||Overbought Stochastic||Strength||0.00%|
|Dec 11||Upper Bollinger Band Touch||Strength||0.00%|
|Dec 10||Upper Bollinger Band Walk||Strength||4.53%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
- Earnings date: 2018-11-14
Osiris Therapeutics, Inc. is a cellular and regenerative medicine company. The Company is focused on researching, developing and marketing products in the wound, orthopedic, and sports medicine markets. The Company operates through Biosurgery business segment, which focuses on products for wound care, orthopedics, and sports medicine to harness the ability of cells and novel constructs to promote the body's natural healing. The Company's products include Grafix, Stravix, TruSkin, Cartiform and BIO4. The Company produces and distributes Grafix for acute and chronic wounds; Stravix for tendon repair; TruSkin for wound closure; Cartiform, a viable cartilage mesh for cartilage repair, and BIO4 for bone growth. The Company's BioSmart cryopreservation process retains the native characteristics and inherent functionality of tissue. Its BioSmart process includes preservation of the three dimensional (3D) matrix, endogenous growth factors, and tissue-resident cells.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more OSIR news...
|52 Week High||14.25|
|52 Week Low||7.3|
|200-Day Moving Average||0.0|
|50-Day Moving Average||10.8214|
|20-Day Moving Average||11.606|
|10-Day Moving Average||12.601|
|Average True Range||0.5469|
|Chandelier Exit (Long, 3 ATRs )||12.6093|
|Chandelier Exit (Short, 3 ATRs )||11.5407|
|Upper Bollinger Band||13.9042|
|Lower Bollinger Band||9.3078|
|Percent B (%b)||1.04|
|MACD Signal Line||0.5449|
|Market Cap||485.09 Million|
|Num Shares||34.5 Million|
|Price-to-Earnings (P/E) Ratio||352.00|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||15.06|
|Resistance 3 (R3)||15.00||14.63||14.89|
|Resistance 2 (R2)||14.63||14.38||14.65||14.84|
|Resistance 1 (R1)||14.35||14.22||14.49||14.41||14.78|
|Support 1 (S1)||13.70||13.73||13.84||13.76||13.38|
|Support 2 (S2)||13.33||13.57||13.35||13.32|
|Support 3 (S3)||13.05||13.33||13.27|
|Support 4 (S4)||13.11|